412 related articles for article (PubMed ID: 30087038)
1. Clinical and prognostic impact of chronotropic incompetence in patients with hypertrophic cardiomyopathy.
Magri D; Agostoni P; Sinagra G; Re F; Correale M; Limongelli G; Zachara E; Mastromarino V; Santolamazza C; Casenghi M; Pacileo G; Valente F; Morosin M; Musumeci B; Pagannone E; Maruotti A; Uguccioni M; Volpe M; Autore C
Int J Cardiol; 2018 Nov; 271():125-131. PubMed ID: 30087038
[TBL] [Abstract][Full Text] [Related]
2. Cardiopulmonary exercise test and sudden cardiac death risk in hypertrophic cardiomyopathy.
Magrì D; Limongelli G; Re F; Agostoni P; Zachara E; Correale M; Mastromarino V; Santolamazza C; Casenghi M; Pacileo G; Valente F; Musumeci B; Maruotti A; Volpe M; Autore C
Heart; 2016 Apr; 102(8):602-9. PubMed ID: 26849900
[TBL] [Abstract][Full Text] [Related]
3. Heart Failure Progression in Hypertrophic Cardiomyopathy - Possible Insights From Cardiopulmonary Exercise Testing.
Magrì D; Re F; Limongelli G; Agostoni P; Zachara E; Correale M; Mastromarino V; Santolamazza C; Casenghi M; Pacileo G; Valente F; Morosin M; Musumeci B; Pagannone E; Maruotti A; Uguccioni M; Volpe M; Autore C
Circ J; 2016 Sep; 80(10):2204-11. PubMed ID: 27628102
[TBL] [Abstract][Full Text] [Related]
4. QT spatial dispersion and sudden cardiac death in hypertrophic cardiomyopathy: Time for reappraisal.
Magrì D; Santolamazza C; Limite L; Mastromarino V; Casenghi M; Orlando P; Pagannone E; Musumeci MB; Maruotti A; Ricotta A; Oliviero G; Piccirillo G; Volpe M; Autore C
J Cardiol; 2017 Oct; 70(4):310-315. PubMed ID: 28341542
[TBL] [Abstract][Full Text] [Related]
5. Chronotropic incompetence and its relation to exercise intolerance in hypertrophic cardiomyopathy.
Efthimiadis GK; Giannakoulas G; Parcharidou DG; Pagourelias ED; Kouidi EJ; Spanos G; Kamperidis V; Gavrielides S; Karvounis H; Styliadis I; Parcharidis GE
Int J Cardiol; 2011 Dec; 153(2):179-84. PubMed ID: 20851477
[TBL] [Abstract][Full Text] [Related]
6. Predictors of Long-Term Outcome in Children with Hypertrophic Cardiomyopathy.
Ziółkowska L; Turska-Kmieć A; Petryka J; Kawalec W
Pediatr Cardiol; 2016 Mar; 37(3):448-58. PubMed ID: 26526335
[TBL] [Abstract][Full Text] [Related]
7. [Predicting value of 2014 European guidelines risk prediction model for sudden cardiac death (HCM Risk-SCD) in Chinese patients with hypertrophic cardiomyopathy].
Li WX; Liu LW; Wang J; Zuo L; Yang F; Kang N; Lei CH
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1033-1038. PubMed ID: 29325362
[No Abstract] [Full Text] [Related]
8. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.
Chan RH; Maron BJ; Olivotto I; Pencina MJ; Assenza GE; Haas T; Lesser JR; Gruner C; Crean AM; Rakowski H; Udelson JE; Rowin E; Lombardi M; Cecchi F; Tomberli B; Spirito P; Formisano F; Biagini E; Rapezzi C; De Cecco CN; Autore C; Cook EF; Hong SN; Gibson CM; Manning WJ; Appelbaum E; Maron MS
Circulation; 2014 Aug; 130(6):484-95. PubMed ID: 25092278
[TBL] [Abstract][Full Text] [Related]
9. Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.
Lu DY; Pozios I; Haileselassie B; Ventoulis I; Liu H; Sorensen LL; Canepa M; Phillip S; Abraham MR; Abraham TP
J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478967
[TBL] [Abstract][Full Text] [Related]
10. Hypertrophic Cardiomyopathy-Related Sudden Cardiac Death in Young People in Ontario.
Weissler-Snir A; Allan K; Cunningham K; Connelly KA; Lee DS; Spears DA; Rakowski H; Dorian P
Circulation; 2019 Nov; 140(21):1706-1716. PubMed ID: 31630535
[TBL] [Abstract][Full Text] [Related]
11. Global longitudinal strain is associated with heart failure outcomes in hypertrophic cardiomyopathy.
Reant P; Mirabel M; Lloyd G; Peyrou J; Lopez Ayala JM; Dickie S; Bulluck H; Captur G; Rosmini S; Guttmann O; Demetrescu C; Pantazis A; Tome-Esteban M; Moon JC; Lafitte S; McKenna WJ
Heart; 2016 May; 102(10):741-7. PubMed ID: 26857213
[TBL] [Abstract][Full Text] [Related]
12. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD).
O'Mahony C; Jichi F; Pavlou M; Monserrat L; Anastasakis A; Rapezzi C; Biagini E; Gimeno JR; Limongelli G; McKenna WJ; Omar RZ; Elliott PM;
Eur Heart J; 2014 Aug; 35(30):2010-20. PubMed ID: 24126876
[TBL] [Abstract][Full Text] [Related]
13. Insights from Cardiopulmonary Exercise Testing in Pediatric Patients with Hypertrophic Cardiomyopathy.
Gallo G; Mastromarino V; Limongelli G; Calcagni G; Maruotti A; Ragni L; Valente F; Musumeci MB; Adorisio R; Rubino M; Autore C; Magrì D
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33801562
[TBL] [Abstract][Full Text] [Related]
14. Validation of the HCM Risk-SCD model in patients with hypertrophic cardiomyopathy following alcohol septal ablation.
Liebregts M; Faber L; Jensen MK; Vriesendorp PA; Hansen PR; Seggewiss H; Horstkotte D; Adlova R; Michels M; Bundgaard H; Ten Berg JM; Veselka J
Europace; 2018 Sep; 20(FI2):f198-f203. PubMed ID: 29016960
[TBL] [Abstract][Full Text] [Related]
15. Cardiopulmonary Exercise Testing and Prognosis in Hypertrophic Cardiomyopathy.
Coats CJ; Rantell K; Bartnik A; Patel A; Mist B; McKenna WJ; Elliott PM
Circ Heart Fail; 2015 Nov; 8(6):1022-31. PubMed ID: 26374874
[TBL] [Abstract][Full Text] [Related]
16. Modes of death and clinical outcomes in adult patients with hypertrophic cardiomyopathy in Thailand.
Songsirisuk N; Kittipibul V; Methachittiphan N; Charoenattasil V; Zungsontiporn N; Spanuchart I; Buppajarntham S; Mankongpaisarnrung C; Satitthummanid S; Srimahachota S; Chattranukulchai P; Boonyaratavej Songmuang S; Puwanant S
BMC Cardiovasc Disord; 2019 Jan; 19(1):1. PubMed ID: 30606129
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular mortality and chronotropic incompetence in systolic heart failure: the importance of a reappraisal of current cut-off criteria.
Magrì D; Corrà U; Di Lenarda A; Cattadori G; Maruotti A; Iorio A; Mezzani A; Giannuzzi P; Mantegazza V; Gondoni E; Sinagra G; Piepoli MF; Fiorentini C; Agostoni P
Eur J Heart Fail; 2014 Feb; 16(2):201-9. PubMed ID: 24464973
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the association between the presence of fragmented QRS and the predicted risk score of sudden cardiac death at 5 years in patients with hypertrophic cardiomyopathy.
Özyılmaz S; Akgül Ö; Uyarel H; Pusuroğlu H; Karayakalı M; Gül M; Çetin M; Satılmışoğlu H; Yıldırım A; Bakır İ
Anatol J Cardiol; 2017 Jul; 18(1):54-61. PubMed ID: 28559533
[TBL] [Abstract][Full Text] [Related]
19. The T-peak-to-T-end interval: a novel ECG marker for ventricular arrhythmia and appropriate ICD therapy in patients with hypertrophic cardiomyopathy.
Dinshaw L; Münch J; Dickow J; Lezius S; Willems S; Hoffmann BA; Patten M
Clin Res Cardiol; 2018 Feb; 107(2):130-137. PubMed ID: 28965260
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the relationship between the ambulatory electrocardiography-based micro T-wave alternans and the predicted risk score of sudden cardiac death at 5 years in patients with hypertrophic cardiomyopathy.
Özyılmaz S; Püşüroğlu H
Anatol J Cardiol; 2018 Sep; 20(3):165-173. PubMed ID: 30152798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
